InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moderna (MRNA) stock has shed roughly 90% of its value since its 2021 peak.
Barchart on MSN
Moderna jumps above 20-day moving average on FDA flu vaccine review. Should you buy MRNA stock here?
Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal influenza vaccine. As the regulatory agency agreed to ...
Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 across the United States, European Union, Canada and Australia. These filings ...
The FDA reversed its decision on the company's flu vaccine application Pharma giant Moderna Inc (NASDAQ:MRNA) is enjoying a boost today, after the U.S. Food & Drug Administration (FDA) accepted the ...
Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the April 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results